Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia

Internal Medicine

Volumn 53, Issue 11, 2014, Pages 1113-1117

  Tamai, Koji ^a   Tachikawa, Ryo ^a   Tomii, Keisuke ^a   Nagata, Kazuma ^a   Otsuka, Kojiro ^a   Nakagawa, Atsushi ^a   Otsuka, Kyoko ^a   Matsumoto, Takeshi ^a   Monden, Kazuya ^a   Takeshita, Jumpei ^a   Tanaka, Kosuke ^a   Kawamura, Takahisa ^a   Otoshi, Takehiro ^a   Fujimoto, Daichi ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Bronchoalveolar lavage; Neutrophilia; Non HIV; Pneumocystis pneumonia; Prognostic factor

Indexed keywords

ALBUMIN; BETA 1, 3 GLUCAN; C REACTIVE PROTEIN; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PENTAMIDINE MESYLATE; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CD4 CD8 RATIO; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTUBATION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LUNG LAVAGE; LYMPHOCYTE; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL; NON HIV PNEUMOCYSTIS PNEUMONIA; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SURVIVAL FACTOR; AGED; CYTOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMONIA, PNEUMOCYSTIS; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POSITIVE-PRESSURE RESPIRATION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84901814205     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.0520     Document Type: Article

References (23)

1. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 34: 1098-1107, 2002.
2. Arend SM, Kroon FP, van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 155: 2436-2441, 1995.
3. Benfield TL, Helweg-Larsen J, Bang D, Junge J, Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest 119: 844-851, 2001.
4. Azoulay E, Parrot A, Flahault A, et al. AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia. Am J Respir Crit Care Med 160: 493-499, 1999.
5. Festic E, Gajic O, Limper AH, Aksamit TR. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 128: 573-579, 2005.
6. Hardak E, Neuberger A, Yigla M, et al. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection. Respirology 17: 681-686, 2012.
7. Zahar JR, Robin M, Azoulay E, Fieux F, Nitenberg G, Schlemmer B. Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis 35: 929-934, 2002.
8. Ewig S, Bauer T, Schneider C, et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 8: 1548-1553, 1995.
9. Enomoto T, Azuma A, Kohno A, et al. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection. Respirology 15: 126-131, 2010.
10. Bang D, Emborg J, Elkjaer J, Lundgren JD, Benfield TL. Independent risk of mechanical ventilation for AIDS-related Pneumocystis carinii pneumonia associated with bronchoalveolar lavage neutrophilia. Respir Med 95: 661-665, 2001.
11. Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 139: 1336-1342, 1989.
12. Limper AH, Offord KP, Smith TF, Martin WJ 2nd. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140: 1204-1209, 1989.
13. Smith RL, el-Sadr WM, Lewis ML. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 93: 60-64, 1988.
14. Oren I, Hardak E, Finkelstein R, Yigla M, Sprecher H. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia. Am J Med Sci 342: 182-185, 2011.
15. Gilbert DN, Moellering RC Jr, Eliopoulos GM, Chambers HF, Saag MS. The Sanford Guide to Antimicrobial Therapy 2012. 42nd ed. Antimicrobial Therapy, Virginia, 2012: 202-209.
16. Kanda Y, Mineishi S, Saito T, et al. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation. Transplantation 73: 568-572, 2002.
17. Bonaccorsi A, Cancellieri A, Chilosi M, et al. Acute interstitial pneumonia: report of a series. Eur Respir J 21: 187-191, 2003.
18. Katzenstein AL. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease: Volume 13 in the Major Problems in Pathology Series. 4th ed. Saunders, New York, 2006: 261-304.
19. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 17: 293-307, 2011.
20. Swain SD, Wright TW, Degel PM, Gigliotti F, Harmsen AG. Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect Immun 72: 5722-5732, 2004.
21. Sage EK, Noursadeghi M, Evans HE, et al. Prognostic value of Creactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia. Int J STD AIDS 21: 288-292, 2010.
22. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 197: 10-17, 2008.
23. Watanabe T, Yasuoka A, Tanuma J, et al. Serum (1→3) 3-Dglucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis 49: 1128-1131, 2009.